Skip to content

The Impact of 3D Anal Fistula Models on Patient Understanding and Decision Making

The Impact of 3D Anal Fistula Models on Patient Understanding and Decision Making

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04069728
Acronym
3DAF
Enrollment
50
Registered
2019-08-28
Start date
2020-11-02
Completion date
2021-08-02
Last updated
2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ano Fistula, Fistula in Ano

Brief summary

An anal fistula is an abnormal communication between the luminal surface of the anorectal canal and the perianal skin. Fistulas can vary in their complexity and can be challenging to treat, due to the anatomical relation to the anal sphincter complex that controls continence. In addition, fistulas can display complex features such as branches, cavities and horseshoes; where the tract travels radially around the anal canal. All these features have a role in determining the most appropriate surgical treatment option, and are key to understanding the surgical decision-making process. This study will determine patient understanding of fistula anatomy, their perception of their own understanding, their rating of how good their clinician's explanation is and how this impacts the decision-making process using standard explanation with 2D images, versus a 3D printed model of a fistula.

Detailed description

Previous work has established a method of using traditional two-dimensional MR images to construct and print 3D models of perianal fistula, however the clinical utility of these models in the outpatient setting and their impact on patient knowledge of disease have not yet been assessed. This study is aimed at understanding how the use of 3D printed models can influence patient understanding of disease and support them in making decisions regarding treatment. Participants attending routine outpatient appointments will have their fistula explained to them using either a standard explanation, or a 3D printed model of a fistula. They will complete a short series of questionnaires and their answers will be analysed to determine if there is any benefit of using 3D models in a clinical consultation.

Interventions

OTHERExplanation with 3D printed fistula model

Explanation of fistula and surgery using a 3D printed model of an anal fistula that depicts the anatomy of the anal canal, the path of the anal fistula and its relation to anatomic structures.

OTHERStandard explanation

Explanation of fistula and treatment using words, diagrams and MRI images as per consultant choice. Standard clinical care.

Sponsors

London North West Healthcare NHS Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Prospective randomised pilot study

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Male and female patients * Aged ≥18 years old * Patients who are new referrals to complex fistula clinic * Patients with an idiopathic or Crohn's perianal fistula * Patients with an intersphincteric or transsphincteric fistula according to Park's classification * Patients who have had MR imaging of their anal fistula prior to consultation * Able to give full informed consent

Exclusion criteria

Patients \< 18 years * Patients with a rectovaginal or pouch fistula * Fistula secondary to malignancy or radiation * Suprasphincteric or extrasphincteric fistulas * Follow up patients * Patients who have no prior MR imaging of their fistula Patients who do not have the capacity to consent

Design outcomes

Primary

MeasureTime frameDescription
Patient understanding of fistula anatomy and surgery5 minutesA score obtained using a non-validated questionnaire that assesses the patient's understanding of their fistula anatomy and the treatment that has been proposed. Scores can range from 0 to 16, with a higher score suggesting better understanding.

Secondary

MeasureTime frameDescription
Patient understanding of their fistula: Patient reported subjective assessment1 minuteA self reported score that patients give for how well they feel they have understood their fistula and proposed surgery. Patients rate how well they understand their fistula on a scale of 1-10, where 1 denotes very poor understanding, and 10 equates to excellent understanding.
Quality of explanation: Patient reported subjective assessment1 minutePatient reported subjective rating of how well their clinician explained their fistula and surgery to them. Four questions where patients rate how well their fistula was explained on a scale of 1 to 10, with 1 equating to very poor understanding and 10 excellent understanding. An additional question asks the patient if the explanation relieved their anxiety (Yes/No). Responses to individual questions will be reported.
Decisional Conflict Scale5 minutesA validated questionnaire that assesses the level of uncertainty a patient has in making a decision. Subscales: Uncertainty: Scores range from 0 (feels extremely certain) to 100 (feels extremely uncertain about best choice) Informed: Scores range from 0 (feels extremely informed) to 100 (extremely uninformed) Values clarity: Scores range from 0 (feels clear about personal values for benefits and risks) to 100 (feels extremely unclear about personal values) Support: Scores range from 0 (feels extremely supported in decision making) to 100 (feels unsupported in decision making) Effective decision: Scores range from 0 (good decision) to 100 (bad decision). The total score is obtained by the addition of each individual score, which is then divided by 16 and multiplied by 25. Scores range from 0 (no decisional conflict) to 100 (extremely high decisional conflict)
3D model utility1 minutePatient reported subjective rating of how useful the 3D model was, using a non- validated questionnaire. This includes 3 questions where patients rate how useful the model is on a scale of 1 to 10, with 1 equating to not very useful, and 10 being very useful. The final question asks patients if they would like to see models in future consultations (Yes/No). Responses to individual questions will be presented.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026